What is in your herbal medicine?

In focus / 25 June 2020

Photo: Paulius Dragunas, Unsplash

Journey into the jungle with the Drug Safety Matters podcast to explore the wild and fascinating world of working safely with herbal medicines.


Herbal substances can be found in a number of pharmaceutical drugs, cosmetics and food supplements – so it's not surprising that using plant names inconsistently can have serious health consequences. But with so much confusion around medicinal plant names, it’s easy to get it wrong.

In the latest epsiode of UMC’s Drug Safety Matters podcast, host Federica Santoro speaks to Bob Allkin from the UK’s Royal Botanic Gardens, Kew to try to clear a path through the undergrowth. Fede and Bob discuss how common, scientific and pharmaceutical plant names differ; how Kew’s Medicinal Plant Names Service works, and the ways in which healthcare and pharmacovigilance professionals can avoid mistakes when working with herbal medicines.

You can subscribe to Drug Safety Matters through your favourite podcast player, or listen on the web here.

Kew Gardens' Bob Allkin joins Federica Santoro in the studio for the Drug Safety Matters podcast. Photo: UMC

Kew Gardens' Bob Allkin joins Federica Santoro in the studio for the Drug Safety Matters podcast. Photo: UMC

Read more:

Bob Allkin's work was also featured in an earlier Uppsala Reports article, Navigating the plant-names jungle.

You may also like


Empowering patients as partners – New podcast episode

A patient’s perspective can lead to new insights that traditional research may overlook. Yet how may we best harness their perspective to improve patient outcomes?

In focus / 06 September 2023

Making fewer medication errors – Education and training remain key

Medication errors significantly contribute to the global number of ADRs per year. How may we best prepare the pharmacovigilance community to tackle the problem?

In focus / 02 April 2024

Guardians of Health: Vigilant surveillance of HIV and TB medicines in Namibia

The introduction of new medications for HIV and TB in Namibia required a more proactive hand in monitoring their safety. For the Namibian TWG, active surveillance was the answer.

In focus / 23 October 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more